Business Consulting Services for Diabetes Med Partners

Transformative Diabetes Treatment with Physiologic Insulin Resensitization

Discover the revolution in diabetes treatment with inSolutions. We offer a cutting-edge approach that targets the root cause of metabolic disorders, not just symptom management.

Our proprietary and multi-patented Physiologic Insulin Resensitization (PIR) system is here to redefine patient care. DELIVER INSULIN AS A HORMONE RATHER THAN A DRUG, imitating the natural glucose metabolism process rather than a conventional medication.

Our PIR system serves to:

1. Mitigate insulin resistance, enhancing insulin sensitivity.

2. Boost the quantity of blood sugar absorbed by cells for superior blood glucose control.

3. Amplify the transformation of sugar into vital energy, bolstering metabolic efficiency.

4. Uplift cellular energy enabling the restoration and regeneration of impaired tissues and organs.

Empirical evidence demonstrates the effectiveness of our revolutionary approach. It has fostered stability and in certain instances, the reversal of complications linked to diabetes and other metabolic disorders.

Are you prepared to be an active player in transforming your metabolic treatments? Choose inSolutions - the innovative solution for metabolic disorders."

Enhance Your Practice with Leading InSolutions: Your Path to Seamless Integration Begins Here

Are you a healthcare provider aiming to elevate your practice with cutting-edge inSolutions? Look no further. Our team specializes in guiding you through every stage of the integration process. We offer comprehensive support that includes expert training, efficient scheduling, strategic procurement, dynamic marketing strategies, impactful launch planning, targeted physician outreach, and tactics for service growth and expansion. Elevate your practice today – get in touch with our specialists to discover how inSolutions can transform your patient care services and profitability.”

'Physiologic hormone administration improves HbA1C in Native Americans with Type 2 diabetes: A retrospective study and review of insulin secretion and action'

A retrospective study and review of insulin secretion and action" focuses on the effect of physiologic hormone administration on HbA1C levels in Native Americans with Type 2 diabetes. It includes a 6-month retrospective chart review of metabolic outcomes in 10 Native American individuals. Key findings include significant reductions in HbA1C, fasting glucose, insulin resistance, and triglycerides after the treatment. The study highlights the potential of this therapy to improve metabolic syndrome components and suggests the need for further investigation through randomized controlled trials [oai_citation:1,Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: A retrospective study and review of insulin secretion and action - PubMed](https://pubmed.ncbi.nlm.nih.gov/37580916

'Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology'

This study reviews the effectiveness of physiological insulin resensitization (PIR) for treating insulin resistance, a major cause of type 2 diabetes. Insulin resistance can lead to increased insulin secretion and beta-cell exhaustion, triggering a cascade of issues including islet cell destruction and various long-term complications of diabetes. The study found that PIR, which involves precise administration of insulin, can reverse complications such as neuropathy, diabetic ulcers, nephropathy, retinopathy, and lower HbA1c levels. The research supports PIR's scientific basis, potential for significant treatment effects, and possible cost benefits [oai_citation:1,Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology - PubMed](https://pubmed.ncbi.nlm.nih.gov/35163806/).

'Improved HOMA-IR Insulin Sensitivity and Glycemic Control Utilizing Physiologic Insulin Resensitization'

This study focuses on Type 2 diabetes (T2DM) and a treatment approach called Physiologic Insulin Resensitization (PIR). PIR aims to improve insulin resistance and metabolic dysfunction in T2DM by using precision insulin dosing to mimic the body’s insulin release. The study reports on 12 T2DM patients who showed improvements in diabetic neuropathy symptoms and changes in HOMA-IR (a measure of insulin resistance) after receiving PIR treatment. The results indicate a significant reduction in HOMA-IR and A1C levels, suggesting potential benefits of PIR in managing T2DM complications [oai_citation:1,Improved HOMA-IR Insulin Sensitivity and Glycemic Control Utilizing Physiologic Insulin Resensitization](https://www.fortunejournals.com/articles/improved-homair-insulin-sensitivity-and-glycemic-control-utilizing-physiologic-insulin-resensitization.html).

'Microburst Insulin Infusion: Results of Observational Studies – Carbohydrate Metabolism, Painful Diabetic Neuropathy, and Hospital/Emergency Department Utilization'

Focuses on the effects of microburst insulin infusion (MII) therapy. This therapy aims to more accurately replicate the natural insulin release of a healthy pancreas compared to traditional insulin therapies.

The study includes three observational retrospective studies:

1. **Carbohydrate Metabolism Study**: This part of the study analyzed the impact of MII on metabolic rates using indirect calorimetry, a method that measures oxygen consumption (VO2) and carbon dioxide production (VCO2). The study included 311 patients across 12 centers, with 7,583 individual microburst insulin treatments. The results showed that oxygen consumption and VCO2 production increased significantly over the study period, indicating a higher rate of carbohydrate oxidation. This suggests that MII enhances the body's ability to metabolize carbohydrates more efficiently.

2. **Painful Diabetic Neuropathy (PDN) Study**: In this segment, 412 patients (80% with Type 2 and 20% with Type 1 diabetes) were observed over three months. The treatment effectively eliminated or significantly reduced pain in 93% of the patients with PDN, indicating a substantial improvement in neuropathy symptoms.

3. **Hospital and Emergency Room Utilization Study**: This two-year retrospective study involved 1,524 Type 1 and Type 2 diabetes patients with multiple complications. The results indicated a dramatic reduction in hospital and emergency room visits compared to expected rates, suggesting that MII can significantly lower hospitalization rates and associated costs.

Overall, the study concludes that microburst insulin therapy offers a significant advancement in diabetes treatment by more closely mimicking natural pancreatic function. This approach not only improves carbohydrate metabolism but also substantially reduces neuropathic complications and the need for hospital and emergency services. 

https://www.mdpi.com/1422-0067/23/3/1884

 'Improved Kidney Function Following Physiologic Insulin Resensitization Treatment Modality' 

investigates a new method for treating chronic kidney disease (CKD) in diabetic and pre-diabetic patients. It employs Physiologic Insulin Resensitization (PIR), which closely mimics natural insulin regulation. The treatment showed improvements in kidney function markers like eGFR, BUN, and Creatinine in a small group of male patients. It suggests that better insulin management can positively impact CKD progression in diabetic patients [oai_citation:1,Improved Kidney Function Following Physiologic Insulin ResensitizationTreatment Modality | Auctores](https://auctoresonline.org/article/improved-kidney-function-following-physiologic-insulin-resensitization-treatment-modality)

'Dynamic diabetes solutions: physiologic insulin resensitization' 

focuses on addressing the rising prevalence of type 2 diabetes and its long-term complications like neuropathy, retinopathy, nephropathy, skin ulcers, amputations, and atherosclerotic cardiovascular disease. A key feature of type 2 diabetes is insulin resistance, which leads to increased insulin secretion and eventually to beta-cell exhaustion. This can trigger a cascade leading to islet cell destruction and further complications of diabetes.

The study evaluates the scientific basis for using physiologic insulin resensitization (PIR) as a treatment. PIR involves the precise administration of insulin more physiologically, mimicking the regular bursts of insulin from the pancreas which become irregular in diabetic conditions. The approach has shown consistent evidence of being able to reverse diabetes-associated complications and lower HbA1c levels. This treatment method is not only scientifically sound but also holds significant potential for treatment and cost benefits. 

PubMed](https://pubmed.ncbi.nlm.nih.gov/35163806/

'Reversal of Diabetic Neuropathy Utilizing Physiologic Insulin Resensitization'

focuses on a novel treatment protocol for patients with severe neuropathy symptoms. It demonstrates that this treatment can lead to neuropathy reversal and improved wound healing. The study is significant as it explores a new approach in treating diabetic neuropathy, a common complication of diabetes. https://www.documentcloud.org/documents/23864253-loveridge-reversal-of-diabetic-neuropathy-utilizing-physiologic-insulin-resensitization-case-series_072021-